“Refractory thrombocytopenia after 177Lu-PSMA therapy: bone marrow infiltration (myelophthisis) versus treatment toxicity” (2026) Scientific Reports in Medicine, 3(1), ss. 39–46. doi:10.37609/srinmed.63.